We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

131 hedge funds and large institutions have $84.1M invested in ImmunityBio in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 11

12% more funds holding

Funds holding: 117 → 131 (+14)

10% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 30

4% less call options, than puts

Call options by funds: $4.51M | Put options by funds: $4.7M

1.5% less ownership

Funds ownership: 8.97% → 7.47% (-1.5%)

23% less capital invested

Capital invested by funds: $109M → $84.1M (-$24.6M)

Holders
131
Holders Change
+14
Holders Change %
+11.97%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
33
Reduced
30
Closed
11
Calls
$4.51M
Puts
$4.7M
Net Calls
-$190K
Net Calls Change
-$2.05M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$8.72M
2
AC
Armistice Capital
New York
+$6.98M
3
BlackRock
BlackRock
New York
+$2.64M
4
CS
Credit Suisse
Switzerland
+$1.04M
5
Group One Trading
Group One Trading
Illinois
+$897K

Top Sellers

1
DFCM
Dark Forest Capital Management
Puerto Rico
-$566K
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$537K
3
Jane Street
Jane Street
New York
-$295K
4
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$193K
5
State Street
State Street
Massachusetts
-$116K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$24.8M +$8.72M +4,342,386 +42%
BlackRock
2
BlackRock
New York
$18.3M +$2.64M +1,312,365 +14%
AC
3
Armistice Capital
New York
$5.87M +$6.98M +3,476,000 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$4.74M +$152K +75,731 +3%
State Street
5
State Street
Massachusetts
$4.6M -$116K -57,644 -2%
CS
6
Credit Suisse
Switzerland
$2.59M +$1.04M +517,643 +51%
JP Morgan Chase
7
JP Morgan Chase
New York
$2.45M -$61.3K -30,521 -2%
Northern Trust
8
Northern Trust
Illinois
$1.95M -$18K -8,942 -0.8%
Charles Schwab
9
Charles Schwab
California
$1.77M +$143K +71,387 +7%
AH
10
Allen Holding
New York
$1.16M – – –
National Bank of Canada
11
National Bank of Canada
Quebec, Canada
$1.07M -$193K -96,100 -12%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$876K -$7.19K -3,581 -0.7%
N
13
Nuveen
North Carolina
$807K +$95.5K +47,554 +11%
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$773K +$196K +97,419 +27%
Group One Trading
15
Group One Trading
Illinois
$755K +$897K +446,743 New
Goldman Sachs
16
Goldman Sachs
New York
$723K +$311K +154,644 +57%
Morgan Stanley
17
Morgan Stanley
New York
$672K +$94.9K +47,254 +13%
CCA
18
Clearwater Capital Advisors
Illinois
$667K – – –
HP
19
Harbourvest Partners
Massachusetts
$567K – – –
AllianceBernstein
20
AllianceBernstein
Tennessee
$499K -$7.33K -3,650 -1%
Swiss National Bank
21
Swiss National Bank
Switzerland
$481K – – –
SSWM
22
Sheets Smith Wealth Management
North Carolina
$463K +$9.54K +4,750 +2%
CH
23
CVI Holdings
Delaware
$383K +$456K +226,916 New
NYLIM
24
New York Life Investment Management
New York
$331K -$61.9K -30,818 -14%
Bank of America
25
Bank of America
North Carolina
$319K +$192K +95,770 +103%
1
2 3 4 5

IBRX Hedge Fund Activity: Q3 2023 in Review

131 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q3 2023, worth a combined $84.1M — down 23% from $109M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IBRX positions and 11 closed out — a net gain of 18 holders — while 33 added to existing stakes and 30 trimmed.

The largest buyer was Vanguard Group, adding an estimated $8.72M. The largest seller was Dark Forest Capital Management, exiting entirely with an estimated $566K sold.

  • 131 institutional investors held ImmunityBio (IBRX) as of Q3 2023, up from 117 in Q2 2023.
  • Funds reported $84.1M of ImmunityBio stock for Q3 2023, down 23% quarter-over-quarter.
  • 29 funds opened new ImmunityBio positions in Q3 2023 and 11 closed out, a net change of +18 holders.
  • The largest ImmunityBio buyer in Q3 2023 was Vanguard Group, an estimated $8.72M added.
  • The largest ImmunityBio seller in Q3 2023 was Dark Forest Capital Management, an estimated $566K sold.

Based on aggregated 13F filings for Q3 2023.